InvestorsHub Logo
Followers 9
Posts 1997
Boards Moderated 0
Alias Born 07/03/2009

Re: Stonemoney post# 10222

Monday, 06/13/2011 6:37:23 PM

Monday, June 13, 2011 6:37:23 PM

Post# of 18608
Good find... biomarkers...that must be us (HDVY)... Thanks !

Event status: Not started (Register)
Date and time: Thursday, June 16, 2011 2:00 pm
Eastern Daylight Time (New York, GMT-04:00)
Change time zone
Duration: 1 hour
Description: Presented by:

Judd W. Moul, MD
Professor of Surgery and Chief, Division of Urologic Surgery
Director, Duke Prostate Center
Duke University Medical Center
Durham, NC

At the conclusion of this program, participants will be able to:
• Discuss advantages and disadvantages of prostate cancer screening using prostate specific antigen (PSA)
• Summarize important data and learnings about PSA from recent randomized clinical trials
• Describe appropriate use of PSA, PSA derivatives and other biomarkers for prostate cancer diagnosis and treatment
• Evaluate options for the treatment for clinically localized prostate cancer, with an emphasis on biomarkers for active surveillance and/or diagnosis of disease aggressivenes